Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. DarioHealth Corp. (DRIO) Message Board

Bladder Cancer Urine Tests Promise Better Treatmen

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 188
(Total Views: 210)
Posted On: 08/21/2020 3:11:12 AM
Avatar
Posted By: NetworkNewsWire
Bladder Cancer Urine Tests Promise Better Treatment Outcomes

Some two novel urine tests have been developed that will improve the patients’ outcome for bladder cancer. These tests are significant upgrades of the existing urine tests for bladder cancer. The current urine tests have been inaccurate, invasive, and expensive.

Causes of bladder cancer

Bladder cancer has been causing high death rates as compared to other types of cancer. The many deaths are due to the difficulties and complications in detecting the cancer. Some tests from specific biomarkers have been used and have been giving high rates of false information. The usual methods that have been used over time have been cystoscopy. It involves inserting a camera into the urethra of a patient, which is unpleasant to a lot patients.

The latest urine tests can measure a gene variant called V1 that is elevated in the bladder of the patient who has bladder cancer. Furthermore, the gene extracts sections of the bladder wall, giving a chance for cancer tumors to grow there. It was discovered by Dr. Vinata Lokeshwar, one of the leading scientists at the Department of Molecular Biology and Biochemistry from Medical College of Georgia.

Detecting bladder cancer using the urine test

One of these tests works by measuring the levels of the enzymes that are created by V1. The second method works by measuring the amount of V1 in a patient’s system, depending on the mRNA excreted from urine. Both ways have an accuracy of about 90% in detecting bladder cancer.

These tests have proven to be more trustworthy when it involves high-grade tumors, boasting a 95% success rate in detecting bladder cancer. The piloting studies also gave a clear indication that the V1 test could have the capability of detecting the high-grade tumors. It could detect the tumors six months earlier than the invasive cystoscopy could do. These early detections could lead to increased survival among patients who have bladder cancer.

Using this simplified and accurate urine test for bladder cancer can also offer a patient ample recovery time and it helps in detecting any early forms of recurrence. However, these recurrences are always low in patients with low-grade bladder cancer. For patients with high-grade bladder cancer, their recurrence is always at 80% within three years, making it possible to detect it at the early stages. This is good news to patients who have bladder cancer as these two methods will be of great help to them in reducing mortality rates. Biomedical industry watchers say companies like DarioHealth Corp. (NASDAQ: DRIO) are also working to keep bringing better treatment options, so different patients can have hope that everything is being done to treat their ailments.

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer


(0)
(0)




DarioHealth Corp. (DRIO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us